⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RANI News
Rani Therapeutics Holdings, Inc. Class A Common Stock
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
RANI
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing
globenewswire.com
RANI
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
globenewswire.com
RANI
Form 8-K
sec.gov
RANI
Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer
globenewswire.com
RANI
Form 8-K
sec.gov
RANI
Form 8-K
sec.gov
RANI
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules
globenewswire.com
RANI
Form 8-K
sec.gov
RANI
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition
globenewswire.com
RANI